Vaccinex, Inc. Increase (Decrease) in Deferred Revenue
Vaccinex, Inc. (VCNX) reported Increase (Decrease) in Deferred Revenue of -$63.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2025-04-15
- Vaccinex, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was -$51.00K.
- Vaccinex, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $51.00K.
- Vaccinex, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-06-30 was -$59.00K.
- Vaccinex, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-03-31 was -$4.00K.
- Vaccinex, Inc. increase (decrease) in deferred revenue for fiscal 2024 was -$63.00K, a 200.00% decline from fiscal 2023.
- Vaccinex, Inc. increase (decrease) in deferred revenue for fiscal 2023 was $63.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | -$59.00K derived: sum of 3 quarters · filed 2025-04-15 | -$63.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$8.00K derived: sum of 2 quarters · filed 2024-11-14 | -$12.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$63.00K 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | -$4.00K 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $63.00K 10-K · filed 2025-04-15 | |||
| 2018-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$256.00K 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | -$194.00K 10-Q · filed 2018-08-14 | |||
| 2017-09-30 | $69.00K 10-Q · filed 2018-11-13 |